Nuclear legumain activity in colorectal cancer von Haugen, Mads H, Johansen, Harald T, Pettersen, Solveig J, Solberg, Rigmor, Brix, Klaudia, Flatmark, Kjersti, Maelandsmo, Gunhild M

Volltext

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer von Grinde, Maria T, Hilmarsdottir, Bylgja, Tunset, Hanna Maja, Henriksen, Ida Marie, Kim, Jana, Haugen, Mads H, Rye, Morten Beck, Mælandsmo, Gunhild M, Moestue, Siver A

Volltext

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy von Egeland, Eivind Valen, Seip, Kotryna, Skourti, Eleni, Øy, Geir Frode, Pettersen, Solveig J., Pandya, Abhilash D., Dahle, Maria A., Haugen, Mads H., Kristian, Alexander, Nakken, Sigve, Engebraaten, Olav, Mælandsmo, Gunhild M., Prasmickaite, Lina

Volltext

Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma von Flem-Karlsen, Karine, McFadden, Erin, Omar, Nasrin, Haugen, Mads H, Øy, Geir Frode, Ryder, Truls, Gullestad, Hans Petter, Hermann, Robert, Mælandsmo, Gunhild Mari, Flørenes, Vivi Ann

Volltext

Nuclear cathepsin L activity is required for cell cycle progression of colorectal carcinoma cells von Tamhane, Tripti, lllukkumbura, Rukshala, Lu, Shiying, Maelandsmo, Gunhild M., Haugen, Mads H., Brix, Klaudia

Volltext

The Agaricus blazei-Based Mushroom Extract, Andosan™, Protects against Intestinal Tumorigenesis in the A/J Min/+ Mouse von Hetland, Geir, Eide, Dag M, Tangen, Jon M, Haugen, Mads H, Mirlashari, Mohammad R, Paulsen, Jan E

Volltext

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer von Normann, Lisa Svartdal, Haugen, Mads Haugland, Hongisto, Vesa, Aure, Miriam Ragle, Leivonen, Suvi-Katri, Kristensen, Vessela N, Tahiri, Andliena, Engebraaten, Olav, Sahlberg, Kristine Kleivi, Mælandsmo, Gunhild Mari

Volltext

Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4 von Prasmickaite, Lina, Tenstad, Ellen M., Pettersen, Solveig, Jabeen, Shakila, Egeland, Eivind V., Nord, Silje, Pandya, Abhilash, Haugen, Mads H., Kristensen, Vessela N., Børresen‐Dale, Anne‐Lise, Engebråten, Olav, Mælandsmo, Gunhild M.

Volltext

Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition von Dahl, John Arne, Jung, Inkyung, Aanes, Håvard, Greggains, Gareth D., Manaf, Adeel, Lerdrup, Mads, Li, Guoqiang, Kuan, Samantha, Li, Bin, Lee, Ah Young, Preissl, Sebastian, Jermstad, Ingunn, Haugen, Mads Haugland, Suganthan, Rajikala, Bjørås, Magnar, Hansen, Klaus, Dalen, Knut Tomas, Fedorcsak, Peter, Ren, Bing, Klungland, Arne

Volltext

High expression of the cysteine proteinase legumain in colorectal cancer – Implications for therapeutic targeting von Haugen, Mads H, Boye, Kjetil, Nesland, Jahn Martin, Pettersen, Solveig J, Egeland, Eivind Valen, Tamhane, Tripti, Brix, Klaudia, Maelandsmo, Gunhild M, Flatmark, Kjersti

Volltext

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer von Fleischer, Thomas, Haugen, Mads Haugland, Ankill, Jørgen, Silwal‐Pandit, Laxmi, Børresen‐Dale, Anne‐Lise, Hedenfalk, Ingrid, Hatschek, Thomas, Tost, Jörg, Engebraaten, Olav, Kristensen, Vessela N.

Volltext

Liver X receptors induce antiproliferative effects in basal-like breast cancer von Haugen, Mads Haugland, von der Lippe Gythfeldt, Hedda, Egeland, Eivind Valen, Svartdal Normann, Lisa, Pandya, Abhilash D, Vedin, Lise-Lotte, Juell, Siri, Tenstad, Ellen, Øy, Geir Frode, Kristian, Alexandr, Marangoni, Elisabetta, Sørlie, Therese, Steffensen, Knut, Maelandsmo, Gunhild Mari, Engebraaten, Olav

Volltext

Cystatin E/M suppresses legumain activity and invasion of human melanoma von Briggs, Jon J, Haugen, Mads H, Johansen, Harald T, Riker, Adam I, Abrahamson, Magnus, Fodstad, Øystein, Maelandsmo, Gunhild M, Solberg, Rigmor

Volltext

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors von Seip, Kotryna, Fleten, Karianne G, Barkovskaya, Anna, Nygaard, Vigdis, Haugen, Mads H, Engesæter, Birgit Ø, Mælandsmo, Gunhild M, Prasmickaite, Lina

Volltext

Proteolysis mediated by cysteine cathepsins and legumain—recent advances and cell biological challenges von Brix, Klaudia, McInnes, Joseph, Al-Hashimi, Alaa, Rehders, Maren, Tamhane, Tripti, Haugen, Mads H.

Volltext

A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases von Nygaard, Vigdis, Ree, Anne Hansen, Dagenborg, Vegar Johansen, Børresen-Dale, Anne-Lise, Edwin, Bjørn, Fretland, Åsmund Avdem, Grzyb, Krzysztof, Haugen, Mads H, Mælandsmo, Gunhild M, Flatmark, Kjersti

Volltext

Abstract 927: Fibroblast-induced switching to the invasive phenotype and PI3K-mTOR signaling protects melanoma cells from BRAF inhibitors von Seip, Kotryna, Fleten, Karianne Giller, Barkovskaya, Anna, Nygaard, Vigdis, Haugen, Mads Haugen, Engesæter, Birgit Øvstebø, Mælandsmo, Gunhild Mari, Prasmickaite, Lina

Volltext

AXL inhibition improves BRAF-targeted treatment in melanoma von Nyakas, Marta, Fleten, Karianne Giller, Haugen, Mads Haugland, Engedal, Nikolai, Sveen, Christina, Farstad, Inger Nina, Flørenes, Vivi Ann, Prasmickaite, Lina, Mælandsmo, Gunhild Mari, Seip, Kotryna

Volltext

Trafficking of Full-Length and N-Terminally Truncated Cathepsin B in Human Colorectal Carcinoma Cells von Tamhane, Tripti, Njenga, Robin W., Burden, Roberta E., Büth, Heiko, Maelandsmo, Gunhild M., Haugen, Mads H., Scott, Christopher J., Brix, Klaudia

Volltext

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro von Normann, Lisa Svartdal, Aure, Miriam Ragle, Leivonen, Suvi-Katri, Haugen, Mads Haugland, Hongisto, Vesa, Kristensen, Vessela N., Mælandsmo, Gunhild Mari, Sahlberg, Kristine Kleivi

Volltext